Skip to main content
Autobound logo
10x Genomics, Inc.SEC 8-K

10x Genomics appoints Ansuman Satpathy and Joseph Gilliam to Board of Directors

Read at SEC EDGAR

What happened

On October 28, 2026, 10x Genomics appointed Dr. Ansuman Satpathy and Joseph Gilliam as Class III directors, with Gilliam also named Audit Committee Chair. The appointments may influence strategic initiatives in AI-enabled drug discovery and financial...

Source

Extracted by Autobound

From the Signal API record
Signal
SEC 8-K

What this signalsFilings often name leadership changes, deals and spending plans.

Filed
Nov 2, 2026

More SEC 8-K signals at other companies

The full record

From the Signal API record

Details

CIK
1770787
Accession number
0001628280-26-068867
Metric named
one-time grant of restricted stock units target value per director
Timeframe
Immediate
Filing year
2026
Fiscal year end
10/28
Why it matters
Strategic direction shift
Signal category
Leadership

Topics and mentions

Technologies named

  • AI

Extraction

Confidence
High
Relevance
80%
Sentiment
Positive
Detected
Nov 3, 2026
signal_type
sec-8k
signal_subtype
boardChange

Use this data

Get every SEC 8-K signal for 10x Genomics, Inc. and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at 10x Genomics, Inc. this week?”

    MCP setup guide

  2. Send it to your own tools

    The Signal API returns SEC 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

    Signal API

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONThe record on this page and the API request

GET /v1/signals/d282a91d-60b8-404e-9b54-1ba2897653fb returns this record as JSON. POST /v1/companies/enrich returns every signal for 10xgenomics.com.

{
  "signal_id": "d282a91d-60b8-404e-9b54-1ba2897653fb",
  "signal_type": "sec-8k",
  "signal_subtype": "boardChange",
  "detected_at": "2026-11-03T07:16:05.869+00:00",
  "company": {
    "name": "10x Genomics, Inc.",
    "domain": "10xgenomics.com"
  },
  "data": {
    "detail": "On October 28, 2026, 10x Genomics appointed Dr. Ansuman Satpathy and Joseph Gilliam as Class III directors, with Gilliam also named Audit Committee Chair. The appointments may influence strategic initiatives in AI-enabled drug discovery and financial governance.",
    "metrics": {
      "timeframe": "immediate",
      "dollar_context": "one-time grant of restricted stock units target value per director"
    },
    "summary": "10x Genomics appoints Ansuman Satpathy and Joseph Gilliam to Board of Directors",
    "relevance": 0.8,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1770787/000162828026068867/txg-20261028.htm",
    "filing_date": "2026-11-02",
    "filing_year": 2026,
    "fiscal_year_end": "10/28",
    "sales_relevance": "Strategic direction shift",
    "signal_category": "leadership",
    "technologies_mentioned": [
      "AI"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.